Diabetes

According to the US Department of Health and Human Services Office of Minority Health, Asian Americans are 40% more likely to be diagnosed with diabetes and 60% more likely to be diagnosed with renal disease compared to non-Hispanic whites.

With the creation of a diabetes prevention program, participants are able to make lasting behavioral changes, such as eating healthier, increasing physical activity, and improving problem-solving skills.

When lifestyle changes fail, medication becomes necessary to decrease chances of maternal and newborn complications.

Pharmacists can play a direct role in addressing social disparities of health in low-income communities by building trust and providing expertise to patients.

Because several pharmaceutical companies pulled back from the federal 340B program last fall, many patients with diabetes are now seeing skyrocketing insulin prices, according to Anne Webster, NP, with UnityPoint Health.

The approval of dapagliflozin is the most significant advancement in the treatment of chronic kidney disease in more than 20 years, according to a press release.

A heart rhythm disorder, atrial fibrillation occurs at least twice as frequently in patients with diabetes as those without.

This data could offer additional insights into how the pandemic may be impacting the nation's children, according to the study authors.

A greater understanding of obesity and its impact on cardiovascular health highlights abdominal obesity, sometimes referred to as visceral adipose tissue (VAT), as a cardiovascular disease risk marker.

The study highlights a new role for pregnancy-associated plasma protein A, known as PAPPA, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target.

Patients with COVID-19 and obesity were more likely to require oxygen and had a 73% greater change of requiring invasive mechanical ventilation.

Pharmacists can sort through options to reduce confusion for patients and prescribers

This information will help them understand the patient medical needs during fasting and make proper adjustments in the treatment regimen where necessary.

Long-term societal and economic impacts of the COVID-19 pandemic have promoted urgent responses in many sectors, which could lead to real-world efforts to improve prevention of chronic health conditions.

Pharmacists can play an integral role when it comes to the management of diabetes, whether by educating patients on lifestyle changes, medications, or disease state management.

The global rise of nonalcoholic fatty-liver disease in pediatric populations has highlighted the need to understand the potential cause of this growing trend.

The device remains the same, but will have a larger cartridge that contains 4, 1 mg doses.

Data have demonstrated that some patients with type 1 diabetes have resorted to unregulated DIY systems for disease management due to frustrations with slow progress made by health care providers in the management of their disease.

The research team analyzed CD4-cell gene expression data from a study of HIV-infected people in Africa and Asia.

In addition to the usual considerations of treating pediatric patients, clinicians should consider how pharmacokinetics may differ for children with obesity, according to a session at the 2021 virtual National Association of Pediatric Nurse Practitioners meeting.

Cardiometabolic health risk factors include metabolic syndrome, a cluster of disorders that include excess fat around the waist, insulin resistance, and high blood pressure.

Being diagnosed with diabetes does not make a person more likely to use effective contraception and may actually lead to a drop in the use of certain types of effective contraception.

Aspects of normal life outside of the pandemic could create difficulties for children with type 1 diabetes, including pressures around food in school.

The study compared an investigational drug called basal insulin Fc (BIF) versus insulin degludec, a commercially available long-lasting daily insulin, in patients with type 2 diabetes.

Women with obesity and polycystic ovarian syndrome (PCOS) have an increased risk of developing type 2 diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.